High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration
- PMID: 25633504
- DOI: 10.1148/radiol.14140364
High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration
Abstract
Purpose: To assess whether an association exists between hyperintensity in the dentate nucleus (DN) on unenhanced T1-weighted magnetic resonance (MR) images and previous administration of gadolinium-based contrast agents (GBCAs) that contain different types of gadolinium chelates.
Materials and methods: The institutional review board approved this study. Written informed consent was waived because this was a retrospective study. Evaluated were 127 cases among 360 consecutive patients who underwent contrast agent-enhanced brain MR imaging. Two radiologists conducted visual evaluation and quantitative analysis on unenhanced T1-weighted MR images by using regions of interest. DN-to-cerebellum (DN/cerebellum) signal intensity ratios were calculated and the relationship between DN/cerebellum and several factors was evaluated, including the number of previous linear chelate and/or macrocyclic GBCA administrations by using a generalized additive model. The Akaike information criterion was used in model selection. Interobserver correlation was evaluated with paired t tests and the Lin concordance correlation coefficient.
Results: The images of nine patients (7.1%) showed hyperintensity in the DN. Twenty-three patients (18.1%) received linear GBCAs (median, two patients; maximum, 11 patients), 36 patients (28.3%) received macrocyclic GBCAs (median, two patients; maximum, 15 patients), 14 patients (11.0%) received both types of GBCA (linear [median, two patients; maximum, five patients] and macrocyclic [median, three patients; maximum, eight patients]), and 54 patients (42.5%) had no history of administration of gadolinium chelate. Interobserver correlation was almost perfect (0.992 [95% confidence interval: 0.990, 0.994]). The DN/cerebellum ratio was associated with linear GBCA (P < .001), but not with macrocyclic GBCA exposure (P = .875). According to the Akaike information criterion, only linear GBCA was selected for the final model, and the DN/cerebellum ratio had strong association only with linear GBCA.
Conclusion: Hyperintensity in the DN on unenhanced T1-weighted MR images is associated with previous administration of linear GBCA, while the previous administration of macrocyclic GBCAs showed no such association.
RSNA, 2015
Comment in
-
High T1 Signal Intensity in Dentate Nucleus after Multiple Injections of Linear Gadolinium Chelates.Radiology. 2015 Aug;276(2):616-7. doi: 10.1148/radiol.2015150464. Radiology. 2015. PMID: 26203714 No abstract available.
Similar articles
-
High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.Radiology. 2015 Sep;276(3):836-44. doi: 10.1148/radiol.2015150872. Epub 2015 Jun 16. Radiology. 2015. PMID: 26079490
-
Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.Invest Radiol. 2018 Apr;53(4):246-255. doi: 10.1097/RLI.0000000000000436. Invest Radiol. 2018. PMID: 29300210
-
High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.Radiology. 2014 Mar;270(3):834-41. doi: 10.1148/radiol.13131669. Epub 2013 Dec 7. Radiology. 2014. PMID: 24475844
-
Brain gadolinium deposition after administration of gadolinium-based contrast agents.Jpn J Radiol. 2016 Jan;34(1):3-9. doi: 10.1007/s11604-015-0503-5. Epub 2015 Nov 25. Jpn J Radiol. 2016. PMID: 26608061 Review.
-
The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.PLoS One. 2017 Feb 10;12(2):e0171704. doi: 10.1371/journal.pone.0171704. eCollection 2017. PLoS One. 2017. PMID: 28187173 Free PMC article.
Cited by
-
The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.Metallomics. 2019 Feb 20;11(2):240-254. doi: 10.1039/c8mt00302e. Metallomics. 2019. PMID: 30516229 Free PMC article. Review.
-
Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.Br J Clin Pharmacol. 2018 Nov;84(11):2522-2534. doi: 10.1111/bcp.13718. Epub 2018 Aug 17. Br J Clin Pharmacol. 2018. PMID: 30032482 Free PMC article. Review.
-
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.Invest Radiol. 2019 Nov;54(11):697-703. doi: 10.1097/RLI.0000000000000593. Invest Radiol. 2019. PMID: 31356382 Free PMC article.
-
Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.Radiology. 2018 Nov;289(2):517-534. doi: 10.1148/radiol.2018181151. Epub 2018 Sep 11. Radiology. 2018. PMID: 30204075 Free PMC article. Review.
-
MRI Protocol for Pituitary Assessment in Children with Growth or Puberty Disorders-Is Gadolinium Contrast Administration Actually Needed?J Clin Med. 2021 Oct 6;10(19):4598. doi: 10.3390/jcm10194598. J Clin Med. 2021. PMID: 34640616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical